John Ormiston

2.2k total citations
32 papers, 1.6k citations indexed

About

John Ormiston is a scholar working on Surgery, Cardiology and Cardiovascular Medicine and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, John Ormiston has authored 32 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Surgery, 22 papers in Cardiology and Cardiovascular Medicine and 12 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in John Ormiston's work include Coronary Interventions and Diagnostics (24 papers), Antiplatelet Therapy and Cardiovascular Diseases (12 papers) and Cardiac Imaging and Diagnostics (12 papers). John Ormiston is often cited by papers focused on Coronary Interventions and Diagnostics (24 papers), Antiplatelet Therapy and Cardiovascular Diseases (12 papers) and Cardiac Imaging and Diagnostics (12 papers). John Ormiston collaborates with scholars based in New Zealand, Netherlands and Australia. John Ormiston's co-authors include Dariusz Dudek, Mark Webster, Antonio Colombo, Leif Thuesen, Eduardo Sousa, Jean Fajadet, Wim van der Giessen, Håkan Emanuelsson, Ricardo Seabra‐Gomes and Michael Haude and has published in prestigious journals such as The Lancet, Journal of the American College of Cardiology and American Heart Journal.

In The Last Decade

John Ormiston

32 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
John Ormiston New Zealand 21 1.4k 1.1k 462 424 65 32 1.6k
Tomohisa Tada Germany 20 1.1k 0.8× 1.1k 1.0× 326 0.7× 381 0.9× 60 0.9× 51 1.5k
Klaus Tiroch Germany 21 1.4k 1.0× 1.3k 1.2× 466 1.0× 747 1.8× 65 1.0× 48 2.0k
Édouard Cheneau United States 20 2.0k 1.4× 1.7k 1.6× 718 1.6× 640 1.5× 33 0.5× 77 2.5k
Gerrit Anne van Es Netherlands 15 1.5k 1.1× 1.4k 1.2× 350 0.8× 934 2.2× 23 0.4× 20 2.0k
Philippe Commeau France 17 1.1k 0.8× 785 0.7× 504 1.1× 311 0.7× 55 0.8× 57 1.4k
G Hellige Switzerland 9 1.6k 1.1× 1.7k 1.5× 464 1.0× 519 1.2× 17 0.3× 30 2.1k
Benno Hennen Germany 15 626 0.5× 890 0.8× 456 1.0× 187 0.4× 42 0.6× 36 1.3k
Sara D. Collins United States 17 395 0.3× 832 0.8× 271 0.6× 196 0.5× 54 0.8× 53 1.0k
Sebastian Kufner Germany 22 1.8k 1.3× 1.4k 1.3× 754 1.6× 650 1.5× 21 0.3× 127 2.2k
Quanmin Jing China 18 782 0.6× 1.0k 0.9× 206 0.4× 182 0.4× 27 0.4× 105 1.3k

Countries citing papers authored by John Ormiston

Since Specialization
Citations

This map shows the geographic impact of John Ormiston's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Ormiston with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Ormiston more than expected).

Fields of papers citing papers by John Ormiston

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John Ormiston. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Ormiston. The network helps show where John Ormiston may publish in the future.

Co-authorship network of co-authors of John Ormiston

This figure shows the co-authorship network connecting the top 25 collaborators of John Ormiston. A scholar is included among the top collaborators of John Ormiston based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John Ormiston. John Ormiston is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Serruys, Patrick W., John Ormiston, Robert‐Jan van Geuns, et al.. (2016). A Polylactide Bioresorbable Scaffold Eluting Everolimus for Treatment of Coronary Stenosis. Journal of the American College of Cardiology. 67(7). 766–776. 119 indexed citations
2.
Wijns, William, Maarten J. Suttorp, Leszek Zagozdzon, et al.. (2016). Evaluation of a crystalline sirolimus-eluting coronary stent with a bioabsorbable polymer designed for rapid dissolution: two-year outcomes from the DESSOLVE I and II trials. EuroIntervention. 12(3). 352–355. 14 indexed citations
3.
4.
Wijns, William, Mathias Vrolix, Stefan Verheye, et al.. (2015). Randomised study of a bioabsorbable polymer-coated sirolimus-eluting stent: results of the DESSOLVE II trial. EuroIntervention. 10(12). 1383–1390. 26 indexed citations
5.
Lin, Aaron, Mohammed Alawami, Mark Webster, et al.. (2014). A Review of a Regional Primary Percutaneous Coronary Intervention Service, with a Focus on Door to Reperfusion Times: The 2012 Auckland/Northland Experience. Heart Lung and Circulation. 24(1). 11–20. 1 indexed citations
6.
Buysschaert, Ian, Christophe Dubois, Joseph Dens, et al.. (2013). Three-year clinical results of the Axxess Biolimus A9 eluting bifurcation stent system: the DIVERGE study. EuroIntervention. 9(5). 573–581. 24 indexed citations
7.
8.
Gutiérrez‐Chico, Juan Luis, Frank Gijsen, Evelyn Regar, et al.. (2012). Differences in Neointimal Thickness Between the Adluminal and the Abluminal Sides of Malapposed and Side-Branch Struts in a Polylactide Bioresorbable Scaffold. JACC: Cardiovascular Interventions. 5(4). 428–435. 22 indexed citations
9.
Dudek, Dariusz, Yoshinobu Onuma, John Ormiston, et al.. (2012). Four-year clinical follow-up of the ABSORB everolimus-eluting bioresorbable vascular scaffold in patients with de novo coronary artery disease: the ABSORB trial. EuroIntervention. 7(9). 1060–1061. 101 indexed citations
10.
Meredith, Ian T., Stephen G. Worthley, Robert Whitbourn, et al.. (2010). Long-term clinical outcomes with the next-generation Resolute Stent System: a report of the two-year follow-up from the RESOLUTE clinical trial. EuroIntervention. 5(6). 692–697. 30 indexed citations
11.
Serruys, Patrick W., John Ormiston, Evelyn Regar, et al.. (2010). Three-year results of clinical follow-up after a bioresorbable everolimus-eluting scaffold in patients with de novo coronary artery disease: the ABSORB trial. EuroIntervention. 6(4). 447–453. 95 indexed citations
12.
Kandzari, David E., Antonio Colombo, Seung‐Jung Park, et al.. (2009). Revascularization for Unprotected Left Main Disease. Journal of the American College of Cardiology. 54(17). 1576–1588. 32 indexed citations
13.
Verheye, Stefan, Pierfrancesco Agostoni, Christophe Dubois, et al.. (2009). 9-Month Clinical, Angiographic, and Intravascular Ultrasound Results of a Prospective Evaluation of the Axxess Self-Expanding Biolimus A9-Eluting Stent in Coronary Bifurcation Lesions. Journal of the American College of Cardiology. 53(12). 1031–1039. 63 indexed citations
14.
Abizaid, Alexandre, Fausto Feres, Ricardo A. Costa, et al.. (2008). EXCELLA™ First-in-Man (FIM) study: safety and efficacy of novolimus-eluting stent in de novo coronary lesions. EuroIntervention. 4(1). 53–58. 27 indexed citations
15.
Gladding, Patrick, Mark Webster, Irene Zeng, et al.. (2008). The Pharmacogenetics and Pharmacodynamics of Clopidogrel Response. JACC: Cardiovascular Interventions. 1(6). 620–627. 93 indexed citations
16.
Gladding, Patrick, Mark Webster, Irene Zeng, et al.. (2008). The Antiplatelet Effect of Higher Loading and Maintenance Dose Regimens of Clopidogrel. JACC: Cardiovascular Interventions. 1(6). 612–619. 45 indexed citations
17.
Gladding, Patrick, et al.. (2008). Antiplatelet drug nonresponsiveness. American Heart Journal. 155(4). 591–599. 37 indexed citations
18.
Fajadet, Jean, et al.. (2007). Randomized, double-blind, multicenter study of the Endeavor zotarolimus-eluting phosphorylcholine-encapsulated stent for treatment of native coronary artery lesions. Clinical and angiographic results of the ENDEAVOR II Trial.. PubMed. 55(1). 1–18. 67 indexed citations
19.
Finci, Léo, Sigmund Silber, Eberhard Grube, et al.. (2004). 1044-56 Paclitaxel-eluting stent in complicated lesions or patient subsets: A subanalysis from the TAXUS II study. Journal of the American College of Cardiology. 43(5). A46–A46. 4 indexed citations
20.
Hout, Ben van, Victor Legrand, Eulogio García, et al.. (1998). Randomised comparison of implantation of heparin-coated stents with balloon angioplasty in selected patients with coronary artery disease (Benestent II). The Lancet. 352(9129). 673–681. 499 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Tomohisa Tada Breakdown of academic impact, for papers by Klaus Tiroch Breakdown of academic impact, for papers by Édouard Cheneau Breakdown of academic impact, for papers by Gerrit Anne van Es Breakdown of academic impact, for papers by Philippe Commeau Breakdown of academic impact, for papers by G Hellige Breakdown of academic impact, for papers by Benno Hennen Breakdown of academic impact, for papers by Sara D. Collins Breakdown of academic impact, for papers by Sebastian Kufner Breakdown of academic impact, for papers by Quanmin Jing
Rankless by CCL
2026